GI
CDMO

Gradient Investments’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Gradient Investments’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3
Closed – – 1228
2020
Q1 		$0 Hold
3
– – ﹤0.01% 1268
2019
Q4 		$0 Buy
+3
New +$18 ﹤0.01% 1263

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Gradient Investments's CDMO Position: Q2 2020 in Review

Gradient Investments sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2020, closing a stake of 3 shares.

Gradient Investments first reported a position in CDMO in Q4 2019 and held it in 2 quarters. The position peaked at $0 in Q1 2020. 105 funds tracked by Wall St. Rank hold CDMO as of Q2 2020.

  • Gradient Investments reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Gradient Investments sold 3 Avid Bioservices, Inc. Common Stock shares in Q2 2020.
  • Gradient Investments first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
  • Gradient Investments's Avid Bioservices, Inc. Common Stock position peaked at $0 in Q1 2020.
  • 105 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2020.

Based on Gradient Investments's 13F filing for Q2 2020, filed 10 Jul 2020.